The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dysfunctional CD8+ T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC).
 
Claire Frances Friedman
Honoraria - Aptitude Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - Arch Oncology; Bristol Myers Squibb; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Daiichi Sankyo/UCB Japan (Inst); Genentech (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech; Merck
 
Qin Zhou
No Relationships to Disclose
 
Alexia Iasonos
Stock and Other Ownership Interests - Bristol-Myers Squibb/Sanofi
Consulting or Advisory Role - BrightPath Biotheraputics; Intelligencia; Mylan
 
Aliya Holland
No Relationships to Disclose
 
Lizbeth Ramirez
No Relationships to Disclose
 
Rachel N. Grisham
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Mateon Therapeutics; Regeneron; Signatera
Research Funding - Context Therapeutics (Inst)
Travel, Accommodations, Expenses - EMD Serono
Other Relationship - Aptitude Health; MCM Education; OncLive; Prime Oncology
(OPTIONAL) Uncompensated Relationships - Verastem
 
Robin Guo
No Relationships to Disclose
 
Stuart M. Lichtman
Consulting or Advisory Role - Magellan Health; Remedy One
 
Chrisann Kyi
Honoraria - OncLive/MJH Life Sciences
Research Funding - Bristol Myers Squibb,; Gritstone Bio; Merus
 
Vicky Makker
Consulting or Advisory Role - ArQule; Clovis Oncology; DualityBio; Eisai; Faeth Therapeutics; GlaxoSmithKline; IBM; ITeos Therapeutics; Kartos Therapeutics; Karyopharm Therapeutics; Lilly; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Eisai (Inst); Faeth Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Eisai; Karyopharm Therapeutics; Merck
Other Relationship - IBM
 
Jennifer Jean Mueller
No Relationships to Disclose
 
Roisin Eilish O'Cearbhaill
Honoraria - Curio Science; GlaxoSmithKline; MJH Life Sciences
Consulting or Advisory Role - Aptitude Health; Bayer; Carina Biotech; Fresenius Kabi; GlaxoSmithKline; Immunogen; Regeneron; Seagan
Research Funding - AstraZeneca/Merck (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Genentech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Ludwig Institute for Cancer Research (Inst); Merck/Genentech (Inst); Regeneron (Inst); Sellas Life Sciences (Inst); Stem CentRx (Inst); Syndax (Inst); TapImmune Inc. (Inst); TCR2 Therapeutics (Inst)
Travel, Accommodations, Expenses - Hitech Health
 
Alison M. Schram
Consulting or Advisory Role - Mersana
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Kura Oncology (Inst); Lilly (Inst); Merus (Inst); Northern Biologics (Inst); Pfizer (Inst); PMV Pharma (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst); Surface Oncology (Inst)
 
William P. Tew
No Relationships to Disclose
 
Jason A. Konner
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Research Funding - Immunogen
 
Tiffany A. Troso-Sandoval
Honoraria - Bio Ascend; Biotheranostics/Hologic
Consulting or Advisory Role - AstraZeneca; Guidepoint Global; Qessential Medical Marketing Research
Travel, Accommodations, Expenses - Bio Ascend
 
Andreas Georg Wibmer
No Relationships to Disclose
 
Carol Aghajanian
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; Eisai; Eisai; Mersana; Repare Therapeutics; Roche; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Martee Leigh Hensley
Employment - Sanofi (I)
Stock and Other Ownership Interests - Sanofi (I)
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Tesaro; Thrive, An Exact Sciences Company
Patents, Royalties, Other Intellectual Property - author, Up to Date
 
Dmitriy Zamarin
Stock and Other Ownership Interests - Accurius; Calidi Biotherapeutics; ImmunOs Therapeutics
Consulting or Advisory Role - Agenus; AstraZeneca; Celldex; Crown Bioscience; Genentech/Roche; GlaxoSmithKline; Hookipa Biotech; Memgen; Synlogic; Synthekine; Targovax; Tessa Therapeutics; Xencor
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Plexxikon (Inst)
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)